AMICUS THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Amicus Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q4 2024.
  • Amicus Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 304M shares, a 3.12% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 304M shares, a 3.12% increase from 2023.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 295M shares, a 2.11% increase from 2022.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 289M shares, a 6.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.